ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CQ could markedly promote CML cell apoptosis induced by Hedgehog pathway suppression of imatinib-sensitive or -resistant BCR-ABL+ cells (Zeng et al., 2015).